LAKE FOREST, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted full qualification for ...

As the biopharmaceutical industry evolves, aligning our client programs with our corporate strategy is essential to ensuring long-term success,” said Benedikt von Braunmühl, CEO of Rentschler ...

Laromestrocel (Lomecel-B™) has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for Alzheimer’s disease which provides frequent interactions with the FDA, intensive guidance on ...

“Integrating Dieta’s AI-driven stool imaging directly supports our mission to improve digestive health outcomes and member experiences,” said Bill Snyder, CEO and founder of Cylinder. “This ...

Adds New Partner Practices in Wisconsin and Oregon. IRVING, Texas, March 20, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management – a management services organization that excl ...

AAMI members and non-members may purchase TIR109 on AAMI ARRAY. The guidance is also available as part of an AAMI e-subscription. Members of the trade press covering the sterilization and sterile ...

Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a game-changing patent for a ...

On top of the U.S. Can-Fite patent #10,265,337, Vetbiolix applied for additional new patent applications based on the new data from the dog clinical study that has been concluded recently.

In connection with Mr. Pellegrino’s appointment, Peter Anania has retired from the Board of Directors. Mr. Anania was initially appointed to Precision Optics’ Board in October 2021 in connection with ...

Targeted mutation analysis is a crucial component of modern genomic medicine, enabling the identification of specific genetic variations that contribute to disease development. Unlike whole-genome ...

LOS ANGELES, March 19, 2025 (GLOBE NEWSWIRE) -- Comprehensive Urology launches its new observational study, TEM-C for Chronic ...